Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cumberland Pharmaceuticals Announced Results From Its Phase 2 FIGHT DMD Clinical Trial Were Selected For Late-breaking Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference In Dallas

Author: Benzinga Newsdesk | March 19, 2025 03:07pm

Ifetroban demonstrated significant 5.4% improvement in cardiac function

Posted In: CPIX